Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Ciprofloxacin in Cystic Fibrosis
NCT00645788Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of ciprofloxacin in cystic fibrosis (CF), sponsored by Bayer. Started May 2008; status: completed.
02
Drugs
ciprofloxacin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT00645788.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00645788.